Pricing Log in Create free account

Cytokinetics, Incorporated (CYTK) vs Vaxcyte, Inc. (PCVX)

Cytokinetics, Incorporated and Vaxcyte, Inc. are both Biotechnology companies. Vaxcyte, Inc. is the larger, with a market value of $10.3B against $8.9B — 1.2× the size. Vaxcyte, Inc. has the higher net margin (0.00% vs −1,321.1%) and the lower return on invested capital (−57.3% vs 0.00%). Across the 13 metrics below, Cytokinetics, Incorporated leads on 9 and Vaxcyte, Inc. on 4.

Valuation

Metric CYTK PCVX Biotechnology median
P/E n/m n/m 8.50
P/S 120.92 n/m 9.71
P/B n/m 3.33 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 120.65 n/m 9.21
Earnings yield (11.65%) (11.99%) (33.15%)
Free cash flow yield (7.10%) (9.73%) (25.50%)

Profitability

Metric CYTK PCVX Biotechnology median
Gross margin 87.97% 0.00% 65.16%
Operating margin (1,046.12%) 0.00% 0.00%
Net margin (1,321.12%) 0.00% 0.00%
Free cash flow margin (858.16%) 0.00% 0.00%
Return on equity 329.76% (36.51%) (56.36%)
Return on assets (56.76%) (33.03%) (48.04%)
Return on invested capital 0.00% (57.30%) 0.00%

Growth

Metric CYTK PCVX Biotechnology median
Revenue growth (TTM) (21.07%) — 6.02%
EPS growth (last fiscal year) (24.33%) (48.16%) 30.26%
Revenue growth, 5-year CAGR 9.54% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYTK PCVX Biotechnology median
Debt to equity (6.61) 0.00 0.00
Current ratio 6.66 5.72 4.72
Net debt to EBITDA (0.46) 1.71 0.96

Dividend

Metric CYTK PCVX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYTK PCVX Biotechnology median
Market cap 8.89b 10.27b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack